| 1 |
34983596 | Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages. | 2022 Jan 5 |
1 |
| 2 |
32630417 | Pulmonary Involvement in a Mouse Model of Sjögren's Syndrome Induced by STING Activation. | 2020 Jun 25 |
1 |
| 3 |
29505322 | Activation of Stimulator of Interferon Genes (STING) and Sjögren Syndrome. | 2018 Jul |
1 |
| 4 |
23027866 | 5,6-Dimethylxanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potential. | 2012 Nov 16 |
1 |
| 5 |
21084628 | The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-beta-mediated antiviral activity in vitro and in vivo. | 2011 Mar |
1 |
| 6 |
21819972 | Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulation. | 2011 Nov 1 |
2 |
| 7 |
20824052 | Labeling of oxidizable proteins with a photoactivatable analog of the antitumor agent DMXAA: evidence for redox signaling in its mode of action. | 2010 Sep |
1 |
| 8 |
17473922 | Consequences of increased vascular permeability induced by treatment of mice with 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and thalidomide. | 2008 Mar |
4 |
| 9 |
18954713 | Assessment of the early effects of 5,6-dimethylxanthenone-4-acetic acid using macromolecular contrast media-enhanced magnetic resonance imaging: ectopic versus orthotopic tumors. | 2008 Nov 15 |
1 |
| 10 |
16783963 | Inhibition of DMXAA-induced tumor necrosis factor production in murine splenocyte cultures by NF-kappaB inhibitors. | 2006 |
8 |
| 11 |
15800918 | Mechanisms of tumor vascular shutdown induced by 5,6-dimethylxanthenone-4-acetic acid (DMXAA): Increased tumor vascular permeability. | 2005 Aug 20 |
2 |
| 12 |
16357188 | Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma. | 2005 Dec 15 |
3 |
| 13 |
15060740 | Modulation of thalidomide pharmacokinetics by cyclophosphamide or 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice: the role of tumour necrosis factor. | 2004 May |
2 |
| 14 |
15104247 | Induction of tumour necrosis factor and interferon-gamma in cultured murine splenocytes by the antivascular agent DMXAA and its metabolites. | 2004 Mar 1 |
7 |
| 15 |
12736120 | NF-kappa B activation in vivo in both host and tumour cells by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). | 2003 May |
6 |
| 16 |
14633671 | Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors. | 2003 Nov 15 |
5 |
| 17 |
14649541 | Effect of 3-fluorothalidomide and 3-methylthalidomide enantiomers on tumor necrosis factor production and antitumor responses to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). | 2003 |
6 |
| 18 |
11855749 | Oral activity and pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice. | 2002 Jan |
1 |
| 19 |
12459378 | DMXAA: an antivascular agent with multiple host responses. | 2002 Dec 1 |
2 |
| 20 |
11459201 | Effects of the serotonin receptor antagonist cyproheptadine on the activity and pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (DMXAA). | 2001 Jun |
1 |
| 21 |
11719967 | Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid. | 2001 Nov-Dec |
3 |
| 22 |
9973211 | Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy. | 1999 Feb 1 |
9 |
| 23 |
10360649 | Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid. | 1999 May |
7 |
| 24 |
10416582 | Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice. | 1999 Jul 15 |
7 |
| 25 |
9703279 | Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity. | 1998 Aug |
6 |
| 26 |
9849492 | Antitumour activity of the novel immune modulator 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice lacking the interferon-gamma receptor. | 1998 Jul |
2 |
| 27 |
9891501 | Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid. | 1998 Nov-Dec |
6 |
| 28 |
9066644 | The effect of 5,6-dimethylxanthenone-4-acetic acid on tumour necrosis factor production by human immune cells. | 1997 Jan-Feb |
1 |
| 29 |
9413946 | Production of tumour necrosis factor-alpha by cultured human peripheral blood leucocytes in response to the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488). | 1997 |
1 |
| 30 |
7640215 | Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid. | 1995 Aug |
4 |
| 31 |
7767951 | Induction of tumour necrosis factor-alpha by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid. | 1995 |
5 |
| 32 |
8313372 | Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488). | 1994 Feb 15 |
6 |